We are live on ! Find out more
ADMA icon

ADMA Biologics
ADMA

90 hedge funds and large institutions have $67.7M invested in ADMA Biologics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.57% less ownership

Funds ownership: 40.03% → 33.46% (-6.6%)

14% less funds holding

Funds holding: 105 → 90 (-15)

21% less capital invested

Capital invested by funds: $85.4M → $67.7M (-$17.7M)

43% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 35

47% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 32

80% less call options, than puts

Call options by funds: $712K | Put options by funds: $3.49M

Holders
90
Holders Change
-15
Holders Change %
-14.29%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
35
Closed
32
Calls
$712K
Puts
$3.49M
Net Calls
-$2.77M
Net Calls Change
-$513K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.57M
2
Millennium Management
Millennium Management
New York
+$1.76M
3
CC
Clearline Capital
New York
+$1.01M
4
GCP
GSA Capital Partners
United Kingdom
+$548K
5
E
Ergoteles
New York
+$527K

Top Sellers

1
BlackRock
BlackRock
New York
-$6.29M
2
N
Nuveen
North Carolina
-$1.5M
3
MS
Maven Securities
Jersey
-$1.32M
4
State Street
State Street
Massachusetts
-$1.05M
5
Northern Trust
Northern Trust
Illinois
-$874K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
101
US Bancorp
Minnesota
– -$52K -29,751 Closed
VOYA Investment Management
102
VOYA Investment Management
Georgia
– -$51K -29,207 Closed
State Board of Administration of Florida Retirement System
103
State Board of Administration of Florida Retirement System
Florida
– -$35K -19,873 Closed
SG Americas Securities
104
SG Americas Securities
New York
– -$33K -18,968 Closed
CS
105
Credit Suisse
Switzerland
– -$32K -18,328 Closed
Invesco
106
Invesco
Georgia
– -$31K -17,896 Closed
ProShare Advisors
107
ProShare Advisors
Maryland
– -$31K -17,612 Closed
Prudential Financial
108
Prudential Financial
New Jersey
– -$23K -12,909 Closed
HighTower Advisors
109
HighTower Advisors
Illinois
– -$22K -12,360 Closed
Legal & General Group
110
Legal & General Group
United Kingdom
– -$12K -7,063 Closed
AIP
111
Ameritas Investment Partners
Nebraska
– -$7K -4,185 Closed
Bank of Montreal
112
Bank of Montreal
Ontario, Canada
– -$4K -2,009 Closed
PHK
113
Point72 Hong Kong
Hong Kong
– -$2K -1,397 Closed
CAC
114
Certified Advisory Corp
Florida
– -$2K -1,000 Closed
JCM
115
Jacobi Capital Management
Pennsylvania
– -$1K -800 Closed
EI
116
Ellevest Inc
New York
– -$1K -610 Closed
Fidelity Investments
117
Fidelity Investments
Massachusetts
– +$2 +1 New
1 2 3 4
5

ADMA Hedge Fund Activity: Q2 2021 in Review

90 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q2 2021, worth a combined $67.7M — down 21% from $85.4M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ADMA and 17 opened new positions — a net loss of 15 holders — while 35 trimmed existing stakes and 20 added.

The largest buyer was Vanguard Group, adding an estimated $2.57M. The largest seller was BlackRock, cutting an estimated $6.29M.

  • 90 institutional investors held ADMA Biologics (ADMA) as of Q2 2021, down from 105 in Q1 2021.
  • Funds reported $67.7M of ADMA Biologics stock for Q2 2021, down 21% quarter-over-quarter.
  • 17 funds opened new ADMA Biologics positions in Q2 2021 and 32 closed out, a net change of -15 holders.
  • The largest ADMA Biologics buyer in Q2 2021 was Vanguard Group, an estimated $2.57M added.
  • The largest ADMA Biologics seller in Q2 2021 was BlackRock, an estimated $6.29M sold.

Based on aggregated 13F filings for Q2 2021.